Keywords: marketing, deal, cephalon, drugs, signed, agreement, dompe
Marketing Deal For Cephalon Drugs
Article | 30 June 1998
Cephalon has signed an agreement with Dompe SpA to market, sell anddistribute its Provigil (modafinil) tablets and Myotrophin (mecasermin) injection ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
